pantoprazole and curcumin

pantoprazole has been researched along with curcumin in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	4 (66.67)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Bala, V; Chhonker, YS	1
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF	1
Cavallaro, LG; Cavestro, GM; Comparato, G; Di Mario, F; Fanigliulo, L; Franzè, A; Iori, V; Leandro, G; Maino, M; Martelli, L; Martelli, M; Morana, E; Nouvenne, A; Pilotto, A; Stefani, N	1
Roy, BK; Shukla, HS; Srivastava, AK; Tewari, M	1
Biglarian, O; Ghamarchehreh, ME; Khonche, A; Majeed, M; Panahi, Y; Sahebkar, A; Soflaei, SS; Valizadegan, G	1
Abe, K; Ando, O; Imaoka, T; Karibe, T	1

Reviews

2 review(s) available for pantoprazole and curcumin

Article	Year
Recent developments in anti-Trichomonas research: An update review. European journal of medicinal chemistry, 2018, Jan-01, Volume: 143 Topics: Antiparasitic Agents; Biological Products; Dose-Response Relationship, Drug; Humans; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trichomonas; Trichomonas Infections	2018
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators. European journal of medicinal chemistry, 2022, Jul-05, Volume: 237 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells	2022

Trials

2 trial(s) available for pantoprazole and curcumin

Article	Year
A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure? Helicobacter, 2007, Volume: 12, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetylcysteine; Adult; Aged; Curcumin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactoferrin; Male; Middle Aged; Pantoprazole; Treatment Failure	2007
Adjunctive Therapy with Curcumin for Peptic Ulcer: a Randomized Controlled Trial. Drug research, 2016, Volume: 66, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Curcumin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter pylori; Humans; Male; Pantoprazole; Peptic Ulcer	2016

Article

Year

A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure?

Helicobacter, 2007, Volume: 12, Issue:3

Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetylcysteine; Adult; Aged; Curcumin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactoferrin; Male; Middle Aged; Pantoprazole; Treatment Failure

2007

Adjunctive Therapy with Curcumin for Peptic Ulcer: a Randomized Controlled Trial.

Drug research, 2016, Volume: 66, Issue:8

Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Curcumin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter pylori; Humans; Male; Pantoprazole; Peptic Ulcer

2016

Other Studies

2 other study(ies) available for pantoprazole and curcumin

Article	Year
In Silico Profiling of the Potentiality of Curcumin and Conventional Drugs for CagA Oncoprotein Inactivation. Archiv der Pharmazie, 2015, Volume: 348, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Binding Sites; Clarithromycin; Computer-Aided Design; Curcumin; Drug Design; Helicobacter Infections; Helicobacter pylori; Metronidazole; Molecular Docking Simulation; Pantoprazole; Pattern Recognition, Automated; Protein Binding; Protein Conformation; Proton Pump Inhibitors; Structure-Activity Relationship	2015
Curcumin as an In Vivo Selective Intestinal Breast Cancer Resistance Protein Inhibitor in Cynomolgus Monkeys. Drug metabolism and disposition: the biological fate of chemicals, 2018, Volume: 46, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Biological Availability; Breast Neoplasms; Caco-2 Cells; Cell Line, Tumor; Curcumin; Cytochrome P-450 CYP3A; Female; Humans; Intestinal Absorption; Intestinal Mucosa; Intestines; Lapatinib; Macaca fascicularis; Male; Midazolam; Neoplasm Proteins; Pantoprazole; Quinazolines; Rosuvastatin Calcium; Sulfasalazine; Terfenadine	2018

Article

Year

In Silico Profiling of the Potentiality of Curcumin and Conventional Drugs for CagA Oncoprotein Inactivation.

Archiv der Pharmazie, 2015, Volume: 348, Issue:8

Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Binding Sites; Clarithromycin; Computer-Aided Design; Curcumin; Drug Design; Helicobacter Infections; Helicobacter pylori; Metronidazole; Molecular Docking Simulation; Pantoprazole; Pattern Recognition, Automated; Protein Binding; Protein Conformation; Proton Pump Inhibitors; Structure-Activity Relationship

2015

Curcumin as an In Vivo Selective Intestinal Breast Cancer Resistance Protein Inhibitor in Cynomolgus Monkeys.

Drug metabolism and disposition: the biological fate of chemicals, 2018, Volume: 46, Issue:5

Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Biological Availability; Breast Neoplasms; Caco-2 Cells; Cell Line, Tumor; Curcumin; Cytochrome P-450 CYP3A; Female; Humans; Intestinal Absorption; Intestinal Mucosa; Intestines; Lapatinib; Macaca fascicularis; Male; Midazolam; Neoplasm Proteins; Pantoprazole; Quinazolines; Rosuvastatin Calcium; Sulfasalazine; Terfenadine

2018